Neurodevelopmental Disorders
Normal Development
General Growth Patterns
During the first year of life, a child typically triples their birth weight. By ages 2.5 to 3 years, the child's brain will reach about 66% of its adult size. Early developmental milestones, as established by the CDC and AAP, provide evidence-informed guidelines for developmental surveillance and expectations for progress. Recent guidelines have removed the term "watch and wait" in favor of proactive surveillance recommendations.
Developmental Milestones in Early Years
The First 2 Years
Development follows a cephalocaudal (head to toe) and mediolateral (center to sides) pattern. Key milestones include lifting the head by 4 months, sitting independently by 9 months, walking by 12-15 months, and running by 24 months. Fine motor development can monitor and identify deviations in progress; a significant hand preference should not be seen before the age of 1 year, as typical handedness develops from 18-30 months, and early handedness may indicate neurological injury (Packheiser et al., 2025).
The First 4 Years
Communication development is crucial from birth, specifically non-verbal reciprocal interactions. Boys and bilingual children may exhibit slower expressive language development but typically progress within expected frameworks. Caregiver-child bonding is essential for social and emotional growth, manifesting through facial expression mirroring. The importance of play greatly influences emotional, cognitive, social/motor development, and functional roles.
Ages 5-7
By age 5, the brain reaches approximately 90% of its adult weight. In first grade, pressure increases for children to master academic tasks, including number, letter, and word recognition, alongside writing skills. Cognitive operations begin to develop post age 6, where children learn to manipulate multiple variables in tasks concerning concrete objects.
Ages 7-11
Academic expectations increase in complexity and abstraction, requiring attention to auditory and visual information. Children facing learning disabilities or attention issues may find academic tasks particularly challenging.
Screening Recommendations
The AAP Periodicity Schedule outlines guidelines for developmental surveillance at well-child visits. Autism-specific screening is recommended at 18 and 24 months. It is important to recognize that children with ASD may have skill regressions or plateaus between 12-24 months, and some may be missed during a single screen at 18 months. Screening tools include the MCHAT (Modified Checklist for Autism in Toddlers), which is the primary screening tool, and STAT (Screening Tool for Autism in Toddlers and Young Children), a follow-up tool that includes direct interaction with the child.
Neurodevelopmental Disorders
Neurodevelopmental disorders are characterized by developmental deficits leading to impairments in personal, social, academic, or occupational functioning. ADHD is identified as the most prevalent neurodevelopmental disorder, often co-occurring with learning disorders.
Classifications of Neurodevelopmental Disorders
Classifications include Intellectual Disabilities, Communication Disorders, Autism Spectrum Disorders, Attention Deficit/Hyperactivity Disorders (ADD/ADHD), Specific Learning Disorders, Motor Disorders, and other unspecified disorders.
Intellectual Disability
Definition and Classification
Previously termed 'Mental Retardation', Intellectual Disability (ID) is characterized by impairments in intellectual functioning, measured via IQ testing, specifically scoring 2 standard deviations or more below the mean. It also involves deficits in adaptive behavior and functioning, with onset typically occurring before the 18th birthday. According to DSM-5, ID is now viewed as a mental disorder rather than solely a disability, and clinical judgments replace strict IQ scoring requirements. ID has four severity levels: Mild (F70), Moderate (F71), Severe (F72), and Profound (F73).
Signs and Symptoms
Delays in receptive and expressive language skills become apparent around age 2, while motor delays are often noted by age 1. Play and social skills may lag behind expected developmental timelines, and milestones may plateau or regress despite some achievements. History assessments should consider pregnancy, delivery, and perinatal periods, alongside current and past medical history, family genetics, and environmental stressors.
Evaluations Required
A comprehensive physical examination should include head circumference, neurological assessments, and dysmorphology and skin examinations for neurocutaneous stigmata. Neuroimaging is recommended for patients with abnormal physical findings or significant developmental concerns. Consideration of lead levels for children with pica tendencies is necessary.
Treatment Strategies
Treatment may encompass a combination of therapies, including speech and language therapy, occupational and/or physical therapy, special education support, behavioral therapy or counseling, and potential medical interventions, including psychopharmacology.
Alternative Diagnoses
Global Developmental Delay (F88) is reserved for children under 5 who fail to meet expected milestones and are unable to undergo systematic assessments. Unspecified Intellectual Disability (F79) applies to those over 5 where assessment is hindered by factors like blindness or other severe disorders.
Specific Learning Disorder
Definition
Specific Learning Disorder is defined as a neurodevelopmental disorder affected by both heritable and environmental factors, primarily impacting abilities related to reading, written expression, or mathematics. Notably, the disorder indicates underachievement relative to a child's potential and available opportunities.
DSM-5 Classification
Specific Learning Disorder requires specification for impairments, distinguishing between with impairment in reading (F81.0), also known as Dyslexia, characterized by deficits in word reading accuracy, fluency, and comprehension; with impairment in written expression (F81.81), or Dysgraphia, denoting a deficiency in spelling, grammar, punctuation, and overall written expression capabilities; and with impairment in mathematics (F81.2), or Dyscalculia, which involves deficiencies in number sense, arithmetic facts, and mathematical reasoning.
Symptoms and Duration
Symptoms must persist for over 6 months despite targeted interventions. Common disorders include Dyslexia, marked by difficulties related to reading, decoding, and spelling; Dysgraphia, involving issues with handwriting and written communication; and Dyscalculia, presenting challenges in arithmetic and numerical processing.
Dyslexia
Defined in the 1960s, dyslexia is prevalent in approximately 75% of children diagnosed with learning disorders, particularly among those with ADHD. Notable symptoms include slow, inaccurate, and effortful reading, typically observed starting around age 7. Sensitivity to complex grammatical constructions can occur, leading to issues like missing the text's meaning or disorganization in narrative sequences, and resultant anxiety and feelings of frustration are common.
Dysgraphia
Dysgraphia refers to challenges in writing, often correlated with poor handwriting. It is noted in 5-15% of children, especially those with ADHD. Common errors include frequent grammar mistakes, incorrect tenses, omitted words, and failure to follow organizational structures in written language. Issues commonly appear in capitalizing the first letters of sentences and punctuation.
Dyscalculia
Dyscalculia affects about 6% of children, more frequently observed in females compared to males. Characteristics include failure to grasp numbers and arithmetic facts, typically present by grades 2 or 3. Children may rely on rote memorization, leading to unnoticed struggles until advanced math concepts require numerical manipulation, at which point they can become overwhelmed.
Prognosis
Many struggles with dyscalculia can be resolved with appropriate encouragement and tailored educational approaches; early intervention is critical.
Attention Deficit/Hyperactivity Disorder
Definition
Attention Deficit/Hyperactivity Disorder (ADHD) is characterized by symptoms of diminished attention, increased impulsivity, and hyperactivity, affecting 7-8% of prepubescent children, 5% in youth, and 2.5% in adults. Biological underpinnings point to dopaminergic processes in the prefrontal cortex, with genetic, developmental, and psychosocial factors contributing. ADHD often presents significant impacts in social, educational, and interpersonal contexts.
Subtypes
ADHD is classified into several subtypes: Predominantly inattentive (F90.0), Predominantly hyperactive (F90.1), Combined (F90.2), and Unspecified (F90.9).
Diagnostic Criteria
For diagnosis, symptoms of inattention and/or hyperactivity-impulsivity must interfere with functioning or development. Children require six or more symptoms for at least six months, which should be inappropriate to their developmental level and impact social, academic, or work activities. Older adolescents and adults require five or more symptoms, and these symptoms must be observed in two or more settings.
Common Symptoms
Inattention
Those with inattention often fail to pay close attention to details or make careless mistakes. They may have difficulty organizing tasks and activities and are often forgetful in daily activities.
Hyperactivity and Impulsivity
Individuals often fidget or tap hands/feet, or squirm in their seat, and frequently leave their seat when staying seated is expected. They often talk excessively or interrupt others, exhibiting impulsive behaviors such as blurting out answers before questions are fully presented.
Prognosis
Approximately 60-85% of cases persist into adolescence, with hyperactivity remitting first and distractibility persisting longer. Remissions tend to occur between ages 12-20, though persistence raises risks for conduct disorder and substance abuse.
Treatment Options
Medications
Treatment options include Methylphenidate medications such as Ritalin, which works for 3-4 hours, and Concerta, a long-acting version lasting 8-12 hours through a tri-layer release mechanism. Other formulations like Focalin XR can be mixed into food. Amphetamines commonly used include Adderall, which is short-acting with effects lasting 3-4 hours, and Vyvanse, which provides long-lasting effects (up to 14 hours) by complicating the metabolism pathway.
Alternative Treatments
Atomoxetine, an SNRI, offers similar efficacy to stimulants but is not classified as a controlled substance. Other alternatives include Bupropion and Clonidine.
Side Effects
Common side effects across these medications may include weight loss, poor appetite, labile mood, tics, insomnia, growth concerns, and palpitations.
Tourette Disorder
Definition
Tourette Disorder is characterized by the presence of motor or vocal tics occurring multiple times a day, with onset before age 18 and lasting for at least one year. It is often familial and comorbid with OCD; exacerbations can occur during stress, fatigue, or illness.
Treatment Approaches
Treatment approaches include psychological support for both the patient and family, and potential pharmacological interventions such as second-generation antipsychotics (e.g., Risperidone, Ziprasidone) or low-dose Clonidine/Guanfacine.
Autism Spectrum Disorder (ASD)
Historical Context
Originally documented by Leo Kanner in 1943 and Hans Asperger in 1944, the DSM-IV categorized ASD under Pervasive Developmental Disorders (PDD). The DSM-5 reclassified ASD to combine subtypes under a singular disorder, which has led to controversy regarding increased diagnosis rates alongside improved data collection and provider education.
Epidemiology
There is a higher prevalence of ASD in males (1:151 vs. females 1:31), with a significant escalation (289.5%) over the past 12 years in diagnoses reported.
Key Features
Key features of ASD include persistent deficits in social communication and interaction, which manifest as difficulties in social-emotional reciprocity, nonverbal communicative behaviors, and forming relationships. Additionally, individuals exhibit restricted, repetitive patterns of behavior, such as insistence on routines, restricted interests, or sensory sensitivities.
Diagnostic Criteria
Symptoms must manifest before age 3 in at least one of three core areas: social communication impairments, communication difficulties, and restricted interests and repetitive behaviors. A minimum of six symptoms affecting social functioning, communication, and the presence of restricted behaviors are necessary for diagnosis.
Etiology
Potential etiological factors may include ethylmercury exposure, genetic complications, prenatal viral exposure, and mitochondrial dysfunction.
Screening and Evaluation
Diagnosis can be made as early as 14-18 months using the M-CHAT and subsequent follow-up with the STAT tool. Early referral for therapy is critical to avoid developmental delays.
Co-occurring Conditions
Prevalence rates for co-occurring issues within the ASD population include sleep problems (50-80%), gastrointestinal issues (50-80%), anxiety disorders (\sim22-84%), ADHD (\sim30-50%), and self-injurious behaviors, which are a significant concern.
Prognosis and Treatment
Early intervention significantly enhances outcomes; while the lifetime cost of care may range from $$1.2-$2.4 million, correct interventions can reduce these lifetime costs. Treatment methods typically involve speech/language therapy, occupational/behavioral therapy, and sometimes medications to manage aggression or maladaptive behaviors.
Red Flags for Referral
Red flags prompting referral include a lack of babbling or pointing by 12 months, no single words by 16 months, failure to form two-word phrases by 24 months, or any regression in language or social skills at any age.
Conclusion
Clinicians should perform thorough developmental histories and address concerns regarding social interactions, communication, and behavioral issues for proper identification of ASD.